South Korea vs Singapore: Proportion of the target population who received the final dose
South Korea
69.0%
in 2024
Singapore
70.0%
in 2024
South Korea rank
46th
Singapore rank
44th
Proportion of the target population who received the final dose over time
- South Korea
- Singapore
How they compare
Singapore currently reports 70.0% against 69.0% in South Korea, a difference of 1.0%.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was South Korea ahead.
South Korea ranks 46th and Singapore ranks 44th of 108 countries.
Across the 2 decades both report, South Korea averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | South Korea | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.7% | 29.0% | 33.7% | South Korea |
| 2020s | 68.2% | 74.6% | 6.4% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, South Korea or Singapore?
- Singapore, at 70.0% against 69.0% in South Korea as of 2024.
- What is the difference in proportion of the target population who received the final dose of between South Korea and Singapore?
- 1.0%, with Singapore ahead.
- How many years of comparable data are there for South Korea and Singapore?
- 8 years are reported by both, from 2017 to 2024.
- How do South Korea and Singapore rank globally for proportion of the target population who received the final dose of?
- South Korea ranks 46th and Singapore ranks 44th of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.